Literature DB >> 21347718

Phenytoin- and cranial radiotherapy-induced toxic epidermal necrolysis treated with combination therapy: systemic steroid and intravenous immunoglobulin.

E Fidan1, M Fidan, F Ozdemir, H Kavgaci, F Aydin.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare dermatological disease that causes serious morbidity and mortality. It may be caused by antibiotics, anticonvulsants, nonsteroidal anti-inflammatory agents, allopurinol, infections, autoimmune diseases, and radiotherapy. A 49-year-old man was admitted to our hospital because of skin changes. Prophylactic phenytoin was administered, and cranial radiotherapy was planned for brain metastases. During these treatments, erythematous lesions and blisters were observed on his scalp, face, neck, the front and back of his body, and his arms. Detachment of the skin, especially on the back, was also observed. TEN was diagnosed, and phenytoin was discontinued. Methylprednisolone 80 mg/day IV and intravenous immunoglobulin 1 g/kg/day were applied for treatment. After 10 days, skin recovery and re-epithelialization were established, temperature decreased, and mucosal hemorrhage ceased. The patient was discharged after 2 weeks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21347718     DOI: 10.1007/s12032-011-9864-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  10 in total

Review 1.  IVIG for the treatment of toxic epidermal necrolysis.

Authors:  N Mittmann; B C Chan; S Knowles; N H Shear
Journal:  Skin Therapy Lett       Date:  2007-02

2.  [Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy].

Authors:  F A Fernández; E Pintor; R Quesada; F J Garcés
Journal:  Actas Dermosifiliogr       Date:  2007-09

3.  Toxic epidermal necrolysis of the scalp following anticonvulsant use and cranial irradiation.

Authors:  J T Trent; L E Bowes; P Romanelli; F A Kerdel
Journal:  J Cutan Med Surg       Date:  2001 Nov-Dec       Impact factor: 2.092

4.  Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.

Authors:  Yongsheng Yang; Jinhua Xu; Feng Li; Xiaohua Zhu
Journal:  Int J Dermatol       Date:  2009-10       Impact factor: 2.736

Review 5.  Toxic epidermal necrolysis (Lyell's disease).

Authors:  Mario Lissia; Pietro Mulas; Antonio Bulla; Corrado Rubino
Journal:  Burns       Date:  2009-09-18       Impact factor: 2.744

6.  Toxic epidermal necrolysis after cranial radiotherapy and phenytoin treatment.

Authors:  F Oner Dincbas; S Yörük; C Demirkesen; O Uzel; S Koca
Journal:  Onkologie       Date:  2004-08

7.  Brain radiotherapy during treatment with anticonvulsant therapy as a trigger for toxic epidermal necrolysis.

Authors:  Giulio Metro; Simona Pino; Domenica Pellegrini; Giorgio Sacerdoti; Alessandra Fabi
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

8.  Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider.

Authors:  David Aguiar; Roberto Pazo; Ignacio Durán; Josefa Terrasa; Antonio Arrivi; Herminio Manzano; Javier Martín; Julio Rifá
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

9.  Stevens-Johnson Syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy.

Authors:  Nilendu Sarma
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

Review 10.  Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature.

Authors:  Iftikhar Ahmed; Jason Reichenberg; Allison Lucas; James M Shehan
Journal:  Int J Dermatol       Date:  2004-01       Impact factor: 2.736

  10 in total
  1 in total

1.  Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.

Authors:  Liqin Wang; Sheril Varghese; Fatima Bassir; Ying-Chin Lo; Carlos A Ortega; Sonam Shah; Kimberly G Blumenthal; Elizabeth J Phillips; Li Zhou
Journal:  Front Med (Lausanne)       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.